Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-18

Clinical Trial Update: Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of 10 mg Fluomizin (dequalinium chloride) for local treatment of bacterial vaginosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluomizin (dequalinium chloride)

Snippet

Sponsor: Medinova AG | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED